| Company/Division name | MilliporeSigma |
| Parent company | Merck KGaA |
| Type of work | Manufacturing |
| If manufacturing, is the company a contract manufacturer? | Yes |
| Reshoring category: | Foreign Direct Investment |
| Year reshoring announced: | 2021 |
| Year reshoring implemented or to be implemented: | 2025 |
| Country(ies) from which reshored: | Germany |
| City reshored to: | Sheboygan |
| State(s) reshored to: | WI |
| If relevant, work nearshored to: | - |
| Industry(ies): | Medical Equipment & Supplies |
| Product(s) reshored | nitrocellulose membranes for covid test |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Proximity to customers/market, Skilled workforce availability/training, Under-utilized capacity |
